Lisa Stehno-Bittel, Ph.D., Founder and President
Kansas City, MO
Likarda is a biotech company developing cell therapies and delivery systems for pets and people. Likarda’s cell delivery platform enables better encapsulation of cells for therapies, and can be made in durable or degradable formats. The company is able to create microencapsulants using slow-gelling, advanced, biocompatible hydrogels including PEG, hyaluronic acid, and various other materials. This is achieved in a safe, cyto-compatible, biocompatible manner that can be produced at scale. Likarda is developing this platform for use in diabetes, osteoarthritis, joint pain, and inflammation. Likarda’s platform will enable the next generation of cell therapies to succeed for both pets and people.

By using this website you agree to accept our Privacy Policy and Terms & Conditions